Cupid shares: Promoter Aditya Kumar Halwasiya raises stake again; ups holding to 33.45%

Cupid shares: Promoter Aditya Kumar Halwasiya raises stake again; ups holding to 33.45%

The acquisition represents 0.06 per cent of Cupid's total equity. Following the transaction, Halwasiya's personal shareholding in the company rose to 33.45 per cent, while the aggregate shareholding of the promoter and promoter group stood at 46.40 per cent.

Advertisement
    Share:
Cupid reported a strong financial performance for the June quarter of FY27.Cupid reported a strong financial performance for the June quarter of FY27.
Prashun Talukdar
  • Aug 19, 2026,
  • Updated Aug 19, 2026 10:22 AM IST

Cupid Ltd Chairman and Managing Director Aditya Kumar Halwasiya has further increased his stake in the company through an open market purchase of 8,03,000 shares, according to an exchange filing made by the company after market hours on Tuesday.

The acquisition represents 0.06 per cent of Cupid's total equity. Following the transaction, Halwasiya's personal shareholding in the company rose to 33.45 per cent, while the aggregate shareholding of the promoter and promoter group stood at 46.40 per cent.

Advertisement

Related Articles

This was Halwasiya's second disclosed purchase in the company this week. On Monday, Cupid had informed the stock exchanges that he had acquired 13,95,538 shares through an open market transaction.

Together, the two purchases amount to 21,98,538 shares.

Cupid Q1 results

Cupid reported a strong financial performance for the June quarter of FY27. Its net profit rose 194 per cent year-on-year (YoY) to Rs 44.15 crore, compared with Rs 15.01 crore in Q1 FY26.

Total income increased 142 per cent YoY to Rs 156.98 crore in Q1 FY27 from Rs 59.80 crore in the year-ago quarter. EBITDA climbed 265 per cent YoY to Rs 60.06 crore from Rs 16.47 crore.

The company's EBITDA margin improved to 39 per cent in Q1 FY27 from 28 per cent in Q1 FY26, an expansion of 1,127 basis points (bps) YoY.

Advertisement

Commenting on the Q1 earnings, Halwasiya said: "We have commenced FY27 with strong momentum across both our international B2B healthcare and Consumer Healthcare & FMCG businesses. Healthy execution during the quarter, improving order visibility and sustained demand across our core segments have strengthened our confidence in the Company's growth trajectory. Supported by a robust order book, healthy business momentum and strong visibility across our key operating segments, we have enhanced our FY27 guidance to Rs 725 crore - Rs 750 crore in revenue and Rs 210 crore - Rs 225 crore in Net Profit."

Cupid share price

Meanwhile, Cupid shares were trading 2.05 per cent lower at Rs 278.20 in Wednesday's early trade. Despite the decline, the multibagger stock has gained 235.83 per cent over the past six months.

Advertisement

The securities of Cupid are currently placed under the long-term Additional Surveillance Measure (ASM) framework on both BSE and NSE. Exchanges put stocks in short-term or long-term ASM frameworks to caution investors about high volatility in share prices.

Cupid is engaged in the manufacturing and marketing of male and female condoms, water-based personal lubricants and in-vitro diagnostic (IVD) kits. It also has a portfolio of Consumer Healthcare and FMCG products.

Disclaimer: Business Today provides stock market news for informational purposes only and should not be construed as investment advice. Readers are encouraged to consult with a qualified financial advisor before making any investment decisions.

Cupid Ltd Chairman and Managing Director Aditya Kumar Halwasiya has further increased his stake in the company through an open market purchase of 8,03,000 shares, according to an exchange filing made by the company after market hours on Tuesday.

The acquisition represents 0.06 per cent of Cupid's total equity. Following the transaction, Halwasiya's personal shareholding in the company rose to 33.45 per cent, while the aggregate shareholding of the promoter and promoter group stood at 46.40 per cent.

Advertisement

Related Articles

This was Halwasiya's second disclosed purchase in the company this week. On Monday, Cupid had informed the stock exchanges that he had acquired 13,95,538 shares through an open market transaction.

Together, the two purchases amount to 21,98,538 shares.

Cupid Q1 results

Cupid reported a strong financial performance for the June quarter of FY27. Its net profit rose 194 per cent year-on-year (YoY) to Rs 44.15 crore, compared with Rs 15.01 crore in Q1 FY26.

Total income increased 142 per cent YoY to Rs 156.98 crore in Q1 FY27 from Rs 59.80 crore in the year-ago quarter. EBITDA climbed 265 per cent YoY to Rs 60.06 crore from Rs 16.47 crore.

The company's EBITDA margin improved to 39 per cent in Q1 FY27 from 28 per cent in Q1 FY26, an expansion of 1,127 basis points (bps) YoY.

Advertisement

Commenting on the Q1 earnings, Halwasiya said: "We have commenced FY27 with strong momentum across both our international B2B healthcare and Consumer Healthcare & FMCG businesses. Healthy execution during the quarter, improving order visibility and sustained demand across our core segments have strengthened our confidence in the Company's growth trajectory. Supported by a robust order book, healthy business momentum and strong visibility across our key operating segments, we have enhanced our FY27 guidance to Rs 725 crore - Rs 750 crore in revenue and Rs 210 crore - Rs 225 crore in Net Profit."

Cupid share price

Meanwhile, Cupid shares were trading 2.05 per cent lower at Rs 278.20 in Wednesday's early trade. Despite the decline, the multibagger stock has gained 235.83 per cent over the past six months.

Advertisement

The securities of Cupid are currently placed under the long-term Additional Surveillance Measure (ASM) framework on both BSE and NSE. Exchanges put stocks in short-term or long-term ASM frameworks to caution investors about high volatility in share prices.

Cupid is engaged in the manufacturing and marketing of male and female condoms, water-based personal lubricants and in-vitro diagnostic (IVD) kits. It also has a portfolio of Consumer Healthcare and FMCG products.

Disclaimer: Business Today provides stock market news for informational purposes only and should not be construed as investment advice. Readers are encouraged to consult with a qualified financial advisor before making any investment decisions.
Read more!
Advertisement